Bio-Connect

alpha Tubulin antibody

GTX108784
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetTUBA1B
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    alpha Tubulin antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.81 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID10376
  • Target name
    TUBA1B
  • Target description
    tubulin alpha 1b
  • Target synonyms
    K-ALPHA-1, tubulin alpha-1B chain, alpha tubulin, alpha-tubulin ubiquitous, tubulin K-alpha-1, tubulin alpha-ubiquitous chain, tubulin, alpha, ubiquitous
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Spur EM, Althof N, Respondek D, et al. Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes. Toxicology. 2016,353-354:34-47. doi: 10.1016/j.tox.2016.04.010
    Read this paper
  • Ho YC, Wu ML, Su CH, et al. A Novel Protective Function of 5-Methoxytryptophan in Vascular Injury. Sci Rep. 2016,6:25374. doi: 10.1038/srep25374
    Read this paper
  • Jayachandran P, Olmo VN, Sanchez SP, et al. Microtubule-associated protein 1b is required for shaping the neural tube. Neural Dev. 2016,11:1. doi: 10.1186/s13064-015-0056-4
    Read this paper
  • Cheung AK, Ip JC, Lung HL, et al. Polo-like kinase inhibitor Ro5203280 has potent antitumor activity in nasopharyngeal carcinoma. Mol Cancer Ther. 2013,12(8):1393-401. doi: 10.1158/1535-7163.MCT-12-1219
    Read this paper